Wilbanks Smith & Thomas Asset Management’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio CURE Stock Details CURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7,345	Closed	-$334K	–	346
2017 Q3	$334K	Buy	+7,345	New	+$317K	0.03%	235
2015 Q3	–	Sell	-17,120	Closed	-$673K	–	277
2015 Q2	$673K	Buy	+17,120	New	+$593K	0.07%	149
2015 Q1	–	Sell	-42,600	Closed	-$1.06M	–	307
2014 Q4	$1.06M	Buy	+42,600	New	+$1M	0.11%	122
2014 Q3	–	Sell	-72,300	Closed	-$1.3M	–	289
2014 Q2	$1.3M	Buy	+72,300	New	+$1.16M	0.14%	98
2014 Q1	–	Sell	-43,085	Closed	-$596K	–	287
2013 Q4	$596K	Sell	43,085 -56,015	-57%	-$701K	0.07%	150
2013 Q3	$1.06M	Buy	+99,100	New	+$1.03M	0.14%	105

Other funds holding CURE

QIM

Quantitative Investment Management Charlottesville, Virginia $963M AUM 12.95% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $14.2B AUM 20.68% 1-Year Est. Return

CAL

Capital Analysts LLC Fort Washington, Pennsylvania $3.81B AUM 15.52% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

SPI

Santori & Peters Inc Canonsburg, Pennsylvania $321M AUM 27.58% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's CURE Position: Q4 2017 in Review

Wilbanks Smith & Thomas Asset Management sold out of Direxion Daily Healthcare Bull 3X ETF (CURE) in Q4 2017, closing a stake of 7,345 shares — an estimated $334K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in CURE in Q3 2013 and held it in 6 quarters. The position peaked at $1.3M in Q2 2014. 15 funds tracked by Wall St. Rank hold CURE as of Q4 2017.

Wilbanks Smith & Thomas Asset Management reported no remaining Direxion Daily Healthcare Bull 3X ETF position as of Q4 2017 after selling out during the quarter.
Wilbanks Smith & Thomas Asset Management sold 7,345 Direxion Daily Healthcare Bull 3X ETF shares in Q4 2017, an estimated $334K.
Wilbanks Smith & Thomas Asset Management first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q3 2013 and held it in 6 quarters.
Wilbanks Smith & Thomas Asset Management's Direxion Daily Healthcare Bull 3X ETF position peaked at $1.3M in Q2 2014.
15 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q4 2017.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2017, filed 7 Feb 2018.